e-Meet Michael Rice, SVP, BioConsulting, Head of Advanced Therapeutics & Rare Diseases of @Lumanity @ #Sachs_BEF
— Sachs Associates (@SachsAssociates) August 2, 2022
More info at https://t.co/JkmULss5N2#Sachs_BEF #Sachs_SALSW #lifesciences #partnering #bd #licensing #health #investment #startup #healthcare #innovation #biotech pic.twitter.com/hMmdUoqtfU